COMP <GO>
STE vs EW // NET PROFIT MARGIN
STERIS plc (Ireland) (NYSE) VS. Edwards Lifesciences Corporation (NYSE) • 15-METRIC TALLY: STE 5
— EW 8
▲ NET PROFIT MARGIN LEADER: EW
LAST: $227.12 (-2.16%) • MKT CAP: $22.63B
net-margins
13.20%
LAST: $92.01 (-2.57%) • MKT CAP: $54.44B
net-margins
17.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STE VS. EW)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STE | EW | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.20% | 78.00% | -33.80 | EW | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 12.50% | -2.40 | EW | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 35.1x | -18.10 | STE | /valuation <GO> |
| Free Cash Flow Yield | 4.30% | 2.45% | +1.85 | STE | /fcf-yield <GO> |
| Operating Margin | 18.60% | 20.80% | -2.20 | EW | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 13.20% | 17.70% | -4.50 | EW | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | 11.50% | -2.80 | EW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.07% | 0.00% | +1.07 | STE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.40 | 12.36 | -6.96 | EW | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | STE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.4 | 65.1 | -2.70 | EW | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.08 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.9x | 47.2x | -20.30 | STE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.63B | $54.44B | -$31.80B | EW | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STE REV | EW REV | STE GROSS % | EW GROSS % | STE FCF | EW FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.94B | $6.07B | 44.2% | 78.0% | $972.4M | $1.33B |
| FY 2024 | $5.46B | $5.44B | — | 79.5% | $778.0M | $289.9M |
| FY 2023 | $5.14B | $5.01B | — | — | $742.1M | $670.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STE // BETA 1.08
EW // BETA 1.08